1. Home
  2. RTSN

RTSN

Retension Pharmaceuticals Inc. Common Stock

as of 11-06-2026 2:17pm EST

$10.96
+$0.24
+2.24%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq
Founded: 2023 Country:
United States
United States
Employees: N/A City: N/A
Market Cap: 96.2M IPO Year: 2026
Target Price: N/A AVG Volume (30 days): 93.2K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: $10.85 - $18.64 Next Earning Date: 11-16-2026
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A
P/E Ratio: N/A Index: N/A
Free Cash Flow: N/A FCF Growth: N/A

Share on Social Networks: